Conjugated linoleic acid reduces visceral and ectopic lipid accumulation and insulin resistance in chronic severe hypertriacylglycerolemia
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
26059381
DOI
10.1016/j.nut.2015.03.011
PII: S0899-9007(15)00158-6
Knihovny.cz E-resources
- Keywords
- Conjugated linoleic acid, Fatty acid composition, Hypertriacylglycerolmic rats, Insulin sensitivity, Metabolic syndrome, Oxidative stress,
- MeSH
- Dietary Carbohydrates administration & dosage adverse effects MeSH
- Glucose metabolism MeSH
- Hypertriglyceridemia complications diet therapy etiology MeSH
- Insulin blood MeSH
- Insulin Resistance * MeSH
- Liver drug effects metabolism MeSH
- Linoleic Acids, Conjugated administration & dosage pharmacology MeSH
- Muscle, Skeletal drug effects metabolism MeSH
- Rats MeSH
- Lipid Metabolism drug effects MeSH
- Disease Models, Animal MeSH
- Oxidation-Reduction drug effects MeSH
- Dietary Supplements * MeSH
- Body Weight drug effects MeSH
- Adipose Tissue drug effects metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Dietary Carbohydrates MeSH
- Glucose MeSH
- Insulin MeSH
- Linoleic Acids, Conjugated MeSH
OBJECTIVE: The metabolic health effects of conjugated linoleic acid (CLA), which is one of the principal polyunsaturated fatty acids, are controversial and still not fully accepted. The aim of this study was to examine the effects of CLA on adiposity, ectopic lipid accumulation, and insulin-resistant states in a metabolic syndrome model of non-obese hereditary rats with hypertriacylglycerolmia (HHTg). METHODS: Groups of adult male HHTg rats were fed a high-carbohydrate diet (70% sucrose) with a 2% mixture of CLA isomers, or with the same amount of sunflower oil (control group) for 2 mo. RESULTS: CLA supplementation decreased body weight gain (P < 0.05) and visceral adipose tissue weight (P < 0.01), and distinctively reduced serum triacylglycerols (P < 0.01) and triacylglycerol accumulation in the liver, heart, muscle, and aorta. CLA-treated rats exhibited increased insulin sensitivity in the adipose (P < 0.01), a higher release of fatty acids (P < 0.001), and increased adiponectin secretion (P < 0.01).In the skeletal muscle, CLA supplementation was associated with increased glucose oxidation (P < 0.01) and an elevated anti-inflammatory index (P < 0.05), according to phospholipid fatty acid composition. In the liver, CLA reduced the oxidized form of glutathione and elevated the activity of glutathione-dependent antioxidant enzymes. CONCLUSION: Results suggest that CLA supplementation may protect against HHTg-induced dyslipidemia, ectopic lipid deposition, and insulin resistance. Increased glucose oxidation in the skeletal muscle as well as adiponectin secretion may play a role in the mechanism of the CLA action. Results suggest that CLA could reduce the negative consequences of HHTg and metabolic syndrome.
References provided by Crossref.org
Rapid Drop in Coronary Heart Disease Mortality in Czech Male Population-What Was Actually behind It?
High cysteine diet reduces insulin resistance in SHR-CRP rats
Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia
Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome